Skip to content
Inciteful Med

Subtypes and Progression of DM1: What to Expect

Last updated:

Myotonic Dystrophy Type 1 (DM1) is categorized into four subtypes—congenital, childhood, adult-onset, and late-onset—based on when symptoms begin. While larger CTG genetic repeats often indicate earlier and more severe symptoms, individual progression varies greatly.

Key Takeaways

  • • DM1 is divided into congenital, childhood, adult-onset, and late-onset subtypes based on when symptoms first appear.
  • • Congenital DM1 is the most severe form, often presenting at birth with severe muscle weakness and breathing challenges.
  • • Childhood-onset DM1 frequently begins with cognitive, behavioral, or digestive issues rather than physical weakness.
  • • Classic adult-onset DM1 symptoms include progressive muscle weakness, myotonia (inability to relax muscles), and early cataracts.
  • • While the size of your CTG genetic repeat helps predict your subtype, individual disease progression is highly variable.

Because Myotonic Dystrophy Type 1 (DM1) is so variable, doctors categorize the disease into four main subtypes based on when symptoms first appear and how they present [1][2]. While the size of your CTG repeat expansion generally correlates with these categories—with larger repeats often linked to earlier onset—it is not a perfect predictor of your individual journey [3][4].

1. Congenital DM1 (Most Severe)

This form is present at birth or within the first month of life [2]. It is almost exclusively passed from an affected mother to her child and is typically associated with the largest genetic expansions, often over 1,000 repeats [5][6].

  • Key Features: Severe muscle weakness (hypotonia), breathing difficulties that may require a ventilator, and feeding challenges [5][7].
  • Progression: Children who survive the neonatal period often experience improvements in motor function as they grow, though they frequently face significant intellectual and developmental challenges later in life [2][8].

2. Childhood-Onset DM1

Symptoms in this subtype appear after birth but before age 10 [9].

  • Key Features: Unlike adults, children often present first with cognitive or behavioral issues, such as learning disabilities, attention problems, or speech delays [8][2]. Gastrointestinal (GI) issues like constipation or abdominal pain are also very common [2].
  • Progression: Muscle weakness and myotonia (difficulty relaxing muscles) usually develop later, during the teenage years [9].

3. Adult-Onset (Classic) DM1

This is the most common form, with symptoms typically appearing between ages 10 and 40 [1]. Repeat sizes in this group often range broadly, typically from around 50 up to 1,000 repeats [10].

  • Key Features: The “classic” presentation includes progressive weakness in the hands, feet, and face, alongside myotonia (e.g., trouble letting go of a handshake) [1][11]. Early-onset cataracts and heart conduction issues are also hallmark signs [12][13].
  • Progression: Symptoms tend to progress slowly over decades. Daily life may be increasingly affected by fatigue, excessive daytime sleepiness, and a gradual decline in muscle strength [14][15].

4. Late-Onset (Mild) DM1

Symptoms appear after age 40, and the genetic expansion is typically the smallest (often 50 to 150 repeats) [1][16].

  • Key Features: Many individuals in this group have very mild symptoms, such as cataracts or slight muscle weakness that may be mistaken for normal aging [12][1].
  • Progression: This form progresses very slowly, and many people maintain high levels of function and a normal lifespan, often only being diagnosed after a child or grandchild is identified with a more severe form [2].

Understanding Your Path

It is important to remember that these subtypes are helpful “buckets,” but your experience is unique. While these numbers provide a general guide, there is significant overlap between groups. Your repeat length is not an absolute predictor of how severe your symptoms will be [4].

Factors like somatic instability (how the repeat changes in your own tissues over time) and variant repeats (tiny interruptions in the DNA expansion) can cause your symptoms to differ from the “typical” course [17][18]. Regular monitoring of your heart, lungs, and muscle function is the best way to manage the disease regardless of your subtype [19][20].

Frequently Asked Questions

How do doctors determine my DM1 subtype?
Doctors classify DM1 into four main subtypes based on the age when your symptoms first appear and the types of symptoms you experience. While your genetic test results and CTG repeat size are important, your daily symptoms are the key factor in determining your specific path.
What does Myotonic Dystrophy Type 1 look like in children?
Yes. DM1 can be present at birth (congenital) or develop before age 10. Unlike adults, children often first show cognitive, behavioral, or digestive issues, such as learning disabilities or constipation, before developing classic muscle weakness.
Does my CTG repeat size predict exactly how my DM1 will progress?
Larger CTG repeats generally correlate with earlier onset and more severe symptoms, but they are not a perfect predictor. Factors like how the repeat changes in your tissues over time and tiny interruptions in your DNA can cause your individual experience to differ.
What are the first signs of adult-onset DM1?
The classic adult-onset form typically causes progressive weakness in the face, hands, and feet, along with myotonia (difficulty relaxing muscles after contracting them). Other common signs include early-onset cataracts, heart rhythm issues, and significant fatigue.
How can I track my DM1 progression over time?
The best approach is regular monitoring of your heart, lungs, and muscle function by your medical team. This helps catch any changes early so you can adapt your management plan to fit your specific needs, regardless of your subtype.

Questions for Your Doctor

  • • Based on my symptoms and my repeat count, which of the four subtypes do I most likely fit into?
  • • How quickly do symptoms typically change for people in my specific subtype?
  • • Are there specific GI or cognitive screenings we should prioritize if I fall into the childhood or adult-onset category?
  • • If my repeat count doesn't perfectly match my symptoms, are there other factors like 'variant repeats' that we should look for in my genetic report?
  • • What is the best way for us to track my muscle strength and lung function over time to catch changes early?

Questions for You

  • • At what age did you first notice any symptoms, and what were they?
  • • If you have family members with DM1, at what ages did they first start showing symptoms?
  • • What symptoms are currently having the biggest impact on your daily life—is it muscle weakness, fatigue, or something else like digestion?
  • • Have you noticed any new vision changes or cloudiness that could indicate early cataracts?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    [Medical emergency card for Steinert's disease: an unmet need].

    Rosado-Bartolomé A, Domínguez-González C

    Revista de neurologia 2023; (76(1)):15-19 doi:10.33588/rn.7601.2022380.

    PMID: 36544372
  2. 2

    Clinical and genetic characteristics of childhood-onset myotonic dystrophy.

    Stokes M, Varughese N, Iannaccone S, Castro D

    Muscle & nerve 2019; (60(6)):732-738 doi:10.1002/mus.26716.

    PMID: 31520483
  3. 3

    No increase in the CTG repeat size during transmission from parent with expanded allele: false suspicion of contraction phenomenon.

    Goñi Ros N, Sienes Bailo P, González Tarancón R, et al.

    Advances in laboratory medicine 2023; (4(2)):185-194 doi:10.1515/almed-2022-0079.

    PMID: 38075944
  4. 4

    Overview of the Complex Relationship between Epigenetics Markers, CTG Repeat Instability and Symptoms in Myotonic Dystrophy Type 1.

    de Pontual L, Tomé S

    International journal of molecular sciences 2022; (23(7)) doi:10.3390/ijms23073477.

    PMID: 35408837
  5. 5

    Molecular genetics of congenital myotonic dystrophy.

    Lanni S, Pearson CE

    Neurobiology of disease 2019; (132()):104533 doi:10.1016/j.nbd.2019.104533.

    PMID: 31326502
  6. 6

    DMPK hypermethylation in sperm cells of myotonic dystrophy type 1 patients.

    Yanovsky-Dagan S, Cohen E, Megalli P, et al.

    European journal of human genetics : EJHG 2022; (30(8)):980-983 doi:10.1038/s41431-021-00999-3.

    PMID: 34776509
  7. 7

    Corpus Callosum Diffusion Restriction in Neonatal Congenital Myotonic Dystrophy.

    Sakatani N, Ikeda H, Inami Y, et al.

    Cureus 2025; (17(10)):e94776 doi:10.7759/cureus.94776.

    PMID: 41250692
  8. 8

    Myotonic dystrophy type 1: clinical manifestations in children and adolescents.

    Ho G, Carey KA, Cardamone M, Farrar MA

    Archives of disease in childhood 2019; (104(1)):48-52 doi:10.1136/archdischild-2018-314837.

    PMID: 29871899
  9. 9

    Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy.

    Johnson NE, Ekstrom AB, Campbell C, et al.

    Developmental medicine and child neurology 2016; (58(7)):698-705 doi:10.1111/dmcn.12948.

    PMID: 26510705
  10. 10

    Clinical, pathological and genetic characteristics of a pedigree with myotonic dystrophy type 1.

    Liu Q, Zheng YF, Zhu YP, et al.

    Experimental and therapeutic medicine 2015; (10(5)):1931-1936 doi:10.3892/etm.2015.2738.

    PMID: 26640575
  11. 11

    External Ophthalmoplegia and Brainstem White Matter Lesions: Presentation of Myotonic Dystrophy Type 1.

    Igreja L, Ribeiro L, Cardoso M, et al.

    The neurologist 2023; (28(1)):54-56 doi:10.1097/NRL.0000000000000438.

    PMID: 35442941
  12. 12

    Myotonic Muscular Dystrophies.

    Johnson NE

    Continuum (Minneapolis, Minn.) 2019; (25(6)):1682-1695 doi:10.1212/CON.0000000000000793.

    PMID: 31794466
  13. 13

    Heart transplantation in a patient with Myotonic Dystrophy type 1 and end-stage dilated cardiomyopathy: a short term follow-up.

    Papa AA, Verrillo F, Scutifero M, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2018; (37(4)):267-271.

    PMID: 30944906
  14. 14

    Living with adult-onset myotonic dystrophy type 1: a scoping review.

    Allergodt K, Dreyer P, Werlauff U, Handberg C

    Disability and rehabilitation 2025; (47(9)):2246-2257 doi:10.1080/09638288.2024.2396063.

    PMID: 39212084
  15. 15

    Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1.

    Miller JN, Kruger A, Moser DJ, et al.

    Frontiers in neurology 2021; (12()):700796 doi:10.3389/fneur.2021.700796.

    PMID: 34276551
  16. 16

    Robust and accurate detection and sizing of repeats within the DMPK gene using a novel TP-PCR test.

    Leferink M, Wong DPW, Cai S, et al.

    Scientific reports 2019; (9(1)):8280 doi:10.1038/s41598-019-44588-3.

    PMID: 31164682
  17. 17

    Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort.

    Cumming SA, Jimenez-Moreno C, Okkersen K, et al.

    Neurology 2019; (93(10)):e995-e1009 doi:10.1212/WNL.0000000000008056.

    PMID: 31395669
  18. 18

    Identification and characterization of 5' CCG interruptions in complex DMPK expanded alleles.

    Botta A, Rossi G, Marcaurelio M, et al.

    European journal of human genetics : EJHG 2017; (25(2)):257-261 doi:10.1038/ejhg.2016.148.

    PMID: 27876818
  19. 19

    [Myotonic dystrophy type 1 - a rare cause of bradycardia in the young].

    Kataja Knight A, Tidehag L, Mattsson G, Magnusson P

    Lakartidningen 2020; (117()).

    PMID: 31961442
  20. 20

    Sudden Death Caused by Bilateral Diaphragmatic Eventration in Myotonic Dystrophy Type 1.

    Wu S, Prahlow JA

    The American journal of forensic medicine and pathology 2025; (46(4)):330-336 doi:10.1097/PAF.0000000000001073.

    PMID: 40928346

This page provides educational information about Myotonic Dystrophy Type 1 (DM1) subtypes and disease progression. Always consult your neurologist or genetic counselor for personalized guidance on interpreting your genetic report and managing your care.

Stay up to date

Get notified when new research about Steinert myotonic dystrophy is published.

No spam. Unsubscribe anytime.